Published Date: 20-11-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Pneumonia Testing Market, published by KBV research, the LAMEA Pneumonia Testing Market would witness market growth of 12.4% CAGR during the forecast period (2020-2026).
The Brazil market dominated the LAMEA Immunohistochemistry (IHC) Pneumonia Testing Market by Country 2019, growing at a CAGR of 14.4 % during the forecast period. The Argentina market would witness a CAGR of 16.3% during (2020 - 2026). Additionally, The UAE market is exhibiting a CAGR of 15.3% during (2020 - 2026).
The Point-Of-Care (POC) Testing market dominated the Saudi Arabia Pneumonia Testing Market by Method 2019, growing at a CAGR of 11.8 % during the forecast period. The Immunodiagnostics market is estimated to grow at a CAGR of 13% during (2020 - 2026). Additionally, The Molecular Diagnostics market would showcase highest CAGR of 14.8% during (2020 - 2026).
The Diagnostic Centers market dominated the South Africa Pneumonia Testing Market by End User 2019, thereby, achieving a market value of $10.7 million by 2026. The Hospitals market is witnessing a CAGR of 13.7% during (2020 - 2026). Additionally, The HomeCare market is expected to witness highest CAGR of 14.4% during (2020 - 2026).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.
By End User
Unique Offerings from KBV Research